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Abstract
Background: The grade of gastric mucosa atrophy caused by Helicobacter pylori (H. pylori) infection is closely
associated with the risk of gastric cancer, especially of the intestinal type. Interobserver and intraobserver
agreement for endoscopic gastric mucosa atrophy in subjects with H. pylori-uninfected, currently infected and past
infected was investigated.
Methods: Endoscopic images of 91 patients, 34 images per patient, were assessed. The assessors were 4
endoscopist groups: Japanese and Vietnamese experienced (≥7, ≤ 15 year experience with endoscopy) and
Japanese and Vietnamese beginner (≤ 3 year experience) groups. Each group comprised 3 endoscopists. The
grades of atrophy were classified as 3: none to mild (C-0 and C-1), moderate (C-2 and C-3), and severe (O-1, O-2,
and O-3) using the Kimura-Takemoto Classification. After a period of 2 weeks, images of all patients were
reevaluated by the investigators. Interobserver and intraobserver agreement was calculated by kappa statistics.
Results: The kappa values for the interobserver agreement in the groups of Japanese and Vietnamese experienced,
and Japanese and Vietnamese beginner were 0.474, 0.408, 0.291, and 0.373, respectively. The kappa value of
intraobsever agreement in the Japanese and Vietnamese experienced endoscoists ranged from 0.585 to 0.871. On
the other hand, the value in the beginner endoscopists ranged wider than that in experienced endoscopists, from
0.264 to 0.866.
Conclusions: Our results indicated that, although intraobserver agreement for gastric mucosa atrophy was good to
excellent, interobserver agreement was moderate in experienced endoscopists. This suggests that better guidelines
and firm criteria may be needed to properly diagnose and grade gastric atrophy.
Background
Chronic gastritis is a condition mostly caused by Helico-
bacter pylori (H. pylori) infection [1]. An important stage
in the multistep process leading to this condition is the
development of atrophy of the gastric mucosa. Subjects
infected with H. pylori may first develop non-atrophic,
antral-predominant gastritis, a condition associated with
duodenal ulcer, and then atrophic gastritis, a condition
associated with gastric ulcer and cancer. The grade of
gastric mucosa atrophy is closely associated with the
risk of gastric cancer, especially of the intestinal type.
The relative risk of gastric cancer is 1.7 in subjects
with moderate gastric mucosa atrophy and 4.9 in those
with severe gastric mucosa atrophy compared with
those with no or mild gastric mucosa atrophy [2].
To assess the gastric mucosa atrophy histopathologically,
however, the Operative Link for Gastritis Assessment
(OLGA) Staging System was published in 2007 [3]. We pre-
viously examined the correlation between endoscopic gas-
tric mucosa atrophy assessed by the Kimura-Takemoto
Classification system [4] and histopathologic gastric mucosa
atrophy assessed by the OLGA Staging System [5]. The
result was that high-stage OLGA gastritis and extensive
intestinal metaplasia with incomplete subtype were clus-
tered in patients with endoscopic gastric mucosa atrophy
rated as moderate-to-severe.
Several researchers have reported interobserver and
intraobserver agreement in the histopathologic assess-
ment of H. pylori-associated chronic gastritis [6–8].
However, there have been no studies on interobserver
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and intraobserver agreement in the endoscopic assess-
ment of gastric mucosa atrophy. This agreement may
be crucial to estimate the risk of gastric cancer. We
therefore examined interobserver and intraobserver
agreement for endoscopic gastric mucosa atrophy in
subjects with H. pylori-uninfected, currently infected
and past infected, i.e., eradicated, in 12 assessors from
2 Asian countries, Japan, where endoscopy has already




A total of 91 patients who underwent esophagogastro-
duodenoscopy (EGD) in Hiroshima University Hospital
(Hiroshima, Japan) in August 2013 were prospectively
enrolled in this study. Patients with gastric localized le-
sions such as gastric ulcer and cancer, those with a previ-
ous history of gastric surgery, and those who received
proton pump inhibitors within 1 month prior to the study
were excluded. Patients were divided into 3 groups: the H.
pylori-uninfected group, i.e., those who had never been
infected with H. pylori, those with current infection, and
the H. pylori-past infected group, i.e., those with previ-
ously treated infection. H. pylori status was examined with
at least 2 of the following 4 examinations: histologic exam-
ination of 2 biopsies, one from the antrum and the other
from the corpus; serum and urine H. pylori antibody; and
13C-urea breath test. Patients with at least one positive test
were regarded as having current H. pylori infection.
Patients with all tests negative and no history of H. pylori
eradication treatment were regarded as H. pylori-unin-
fected. Patients with all tests negative and history of H.
pylori eradication treatment were regarded as H. pylori-past
infected.
Endoscopic images
Stored images were retrieved from the computerized
database of the Department of Endoscopy, Hiroshima
University Hospital by use of a digital image filing sys-
tem, Nexus (Fujifilm Co., Ltd., Tokyo, Japan). The size
per endoscopic image was approximately 500 kb. These
images were obtained during the EGD procedure with a
GIF-H260 or GIF-H260Z endoscope (Olympus Optical
Co., Ltd., Tokyo, Japan), after obtaining the written in-
formed consent of the patient. The standard image series
consisted of 34 images: 5 of the prepylorus and antrum,
4 of the angulus, 21 of the corpus (9 look-ups and 12
look-downs), and 4 of the cardia and fornix. The data
were presented to the investigators as a PowerPoint
presentation (Microsoft, Redmond, WA, USA) and were
assessed on a 17-inch standard-definition monitor.
Assessors
The assessors were divided into 4 endoscopist groups:
Japanese and Vietnamese experienced (≥ 7, ≤ 15 year
experience with endoscopy) and Japanese and Vietnamese
beginner (≤ 3 year experience) groups. Each group
comprised 3 endoscopists.
Assessment of images
All images of the 91 patients were evaluated by the 4
endoscopist groups. All endoscopists were blinded to the
patients’ clinical information. Each investigator assessed
endoscopic gastric mucosa atrophy using the Kimura-
Takemoto Classification [4]. The atrophic border is de-
fined as the boundary between the pyloric and fundic
gland regions, which is endoscopically recognized by the
difference in color and height of the gastric mucosa be-
tween the two sides of the border (Figs. 1 and 2). The
grades of atrophy were reclassified into 3: none to mild
(C-0 and C-1), moderate (C-2 and C-3), and severe (O-1,
O-2, and O-3).
After a period of 2 weeks had passed, the images of all
91 patients were reevaluated by the assessors, and the
grades of gastric mucosa atrophy were recorded in a
similar fashion. These results were used for the calcula-
tion of intraobserver agreement (kappa value).
Statistical analysis
The interobserver and intraobserver agreements were
calculated by kappa statistics [9]. The agreement re-
sults were defined as follows: poor, ≤ 0.2; mild, 0.2 to
0.4; moderate, 0.4 to 0.6; good, 0.6 to 0.8, and excel-
lent, 0.8 to 1.
Ethical approval




All 91 patients were Japanese with a mean age of 62.5
(standard deviation, 13.4) years, and the male:female
ratio was 34:57 (Table 1). Of the patients, 72 were those
with untreated H. pylori (24 had never been infected and
48 were currently infected at the time of examination),
and 19 were those with H. pylori-past infected.
Assessors
The mean periods of endoscopic experience of the Japanese
experienced (Y.U., Y. S., and T. M.) and the Vietnamese
experienced (Q.D.T., L.H.M., and T.P.L.N.) and Japanese
beginner (H.K., E.S., and M.H.) and Vietnamese beginner
(L.Q.D., V.N.H.T., and N.K.T.N) groups were 9.7, 10.7, 1.7,
and 1.7 years, respectively.
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Concordance rate for diagnosis of gastric mucosa atrophy
by EGD and H. pylori state
Concordance rate for diagnosis of gastric mucosa atro-
phy by EGD and H. pylori state, i.e., none to mild gastric
atrophy and H. pylori-uninfected, and moderate to se-
vere gastric atrophy and H. pylori-currently or past in-
fected, was assessed in each investigator. The rate in
experienced endoscopists ranged from 81.3 % to 92.3 %
(Table 2). On the other hand, the rate in beginner
endoscopists ranged from 70.3 % to 90.1 %, wider than
that in experienced endoscopists.
Grade of gastric mucosa atrophy in patients assessed
According to the first evaluation by the Japanese experi-
enced assessor No. 1, who had the highest concordance
rate for diagnosis of gastric mucosa atrophy by EGD and
H. pylori state in the present study, the number of sub-
jects with none to mild (C-0 and C-1) atrophy was 29,
that with moderate (C-2 and C-3) was 33, and that with
severe (O-1, O-2, and O-3) atrophy was 29.
Interobserver agreement
The Fleiss kappa values for the interobserver agreement
for endoscopic gastric mucosa atrophy in the 4 groups are
listed in Table 3. In all 91 patients, the kappa values in the
Japanese and Vietnamese experienced, and Japanese and
Vietnamese beginner groups were 0.4738, 0.408, 0.2914,
and 0.3730, respectively. The agreement in the experi-
enced groups was moderate, whereas that in the beginner
groups was mild.
Among the 3H. pylori states, uninfected, currently and
past infected, the interobserver agreement in H. pylori-un-
infected, was the highest in each group.
Intraobserver agreement
The kappa values for the intraobserver agreement for
gastric mucosa atrophy in the 4 groups are shown in
Table 4. Two of the 3 Japanese experienced endoscopists
showed excellent agreement, and all 3 of the Vietnamese
experienced endoscopists showed good agreement.
However, the agreement in Japanese and Vietnamese
beginner endoscopists varied from fair to excellent.
Among the 3H. pylori states, uninfected, currently
and past infected, the highest intraobserver agreement
differed assessor by assessor.
Discussion
In the present study, we demonstrated that, although
intraobserver agreement for gastric mucosa atrophy was
good to excellent, interobserver agreement was moder-
ate in experienced endoscopists. This suggests that better
guidelines and firm criteria may be needed to properly
diagnose and grade gastric atrophy. Truly, this is the first
Fig. 1 Representative example of a gastric atrophic border. The atrophic border is the boundary between the pyloric and fundic gland territories,
which is endoscopically recognized by discriminating differences in the color and height of the gastric mucosa
Fig. 2 Classification of gastric mucosa atrophy (Kimura-Takemoto
Classification). Cases of closed-type gastric mucosa atrophy have an
atrophic boundary between the fundic mucosa and the pyloric
mucosa in the antrum or lesser curvature of the gastric body. Cases
of open-type gastric mucosa atrophy have an atrophic boundary in
the lateral wall or greater curvature of the gastric body. C, closed;
O, open
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study on interobserver and intraobserver agreement for
gastric mucosa atrophy by endoscopy.
To assess gastric mucosa atrophy endoscopically, the
Kimura-Takemoto Classification was published in 1969
[4]. Since then, no other classification systems have been
published, and the Kimura-Takemoto Classification is
commonly used not only in research field1,2 but also in
daily practice, especially in East and Southeast Asian
countries, including Japan and Vietnam. The classifica-
tion focuses on the identification of the endoscopic atro-
phic border and its location in the stomach. The original
classification consists of 7 grades, and the complication
has been pointed out. Therefore, in the present study, 3
grades, none to mild, moderate, and severe, was used.
Several researchers have reported interobserver and
intraobserver agreement in the histopathologic assessment
of H. pylori-associated chronic gastritis [6–8]. Although
interobserver agreement among pathologists for intestinal
metaplasia is good to excellent, that for glandular atrophy
is mild to moderate according to these studies. On the
other hand, the interobserver agreement among endosco-
pists for gastric mucosa atrophy was moderate in experi-
enced endoscopists in the present study. The agreement
was a quite similar result to that for glandular atrophy
among pathologists. In addition, it has been reported that
interobserver agreement for glandular atrophy among
experienced gastrointestinal pathologists (moderate) was
better than that among less-experienced pathologists
(mild) [6]. In the present study, a similar result was
obtained: interobserver agreement for gastric atrophy was
higher in the experienced group than in the beginner
group, in both the Japanese and Vietnamese endoscopists.
These results suggest that this classification requires years
of training to master well.
There has been one report that examined the relation-
ship between OLGA and the Operative Link for Gastric
Intestinal Metaplasia (OLGIM) Staging and endoscopic
findings [10]. In the study, narrow-band imaging magni-
fying endoscopy was used. Degree of correspondence
between endoscopic scores and histopathologic scores
was 69.1 % for the antrum and 72.7 % for the corpus,
i.e., good correspondence. To grade gastric mucosa atro-
phy histopathologically, gastric biopsy samples are needed.
Biopsy could cause massive bleeding. In addition to the
bleeding risk, the histopathologic grading costs a lot com-
pared with endoscopic grading does. Thus, endoscopic
grading of gastric mucosa atrophy may be more beneficial
than histopathologic grading. Examining the interobserver
and intraobserver agreement for gastric mucosa atrophy
by endoscopy is of great interest.
A good interobserver agreement could not be reached
both in Japan and Vietnam, although good to excellent
intraobserver agreement could be, in the present study.
Of course, a perfect agreement by endoscopists was im-
possible because assessments of gastric mucosa atrophy
were based on their subjects. However, better agree-
ment may be needed to increase the reproducibility of
the endoscopic findings. The criteria for grading endo-
scopic gastric atrophy should be improved. Simpler,
well-defined criteria will improve the agreement. The
OLGA Staging System is the system to assess the gas-
tric mucosa atrophy histopathologically. In the system,
glandular atrophy of the antrum and the corpus is
evaluated, then, the stage is settled. Similar endoscopic
system may work well.
Recently, H. pylori eradication treatment has been
widely applied. Edema, rugal hyperplasia, and diffuse
spotty erythema are characteristic endoscopic findings
of H. pylori-associated chronic gastritis [11]. Signifi-
cant changes in endoscopic findings of gastric mucosa
after successful eradication appear as mottled patchy
erythema [11]. Disappearance of spotty redness and
the appearance of gastric flat erosion are also associ-
ated with successful eradication [12]. These changes
may be caused by vanishing of the inflammation of the
Table 2 Concordance rate for diagnosis of gastric atrophy by
EGD and H. pylori state in each assessor
Assessor Experience (y) Concordance rate (%)
Japanese experienced No. 1 10 92.3
Japanese experienced No. 2 10 88.0
Japanese experienced No. 3 9 86.8
Vietnamese experienced No. 1 10 90.1
Vietnamese experienced No. 2 7 81.3
Vietnamese experienced No. 3 15 86.8
Japanese beginner No. 1 3 90.1
Japanese beginner No. 2 1 73.6
Japanese beginner No. 3 1 84.6
Vietnamese beginner No. 1 2 87.9
Vietnamese beginner No. 2 2 70.3
Vietnamese beginner No. 3 1 83.5
Table 1 Patients’ characteristics
Characteristics All (n = 91) H. pylori-uninfected (n = 24) H. pylori-currently infected (n = 48) H. pylori-past infected (n = 19)
Age (y) (mean, SD*) 62.5, 13.8 53.2, 12.9 63.3, 11.1 73.3, 11.8
Male/female 49/42 13/11 25/23 11/8
*SD, standard deviation
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gastric mucosa. We hypothesized that the assessment
of gastric atrophy would be easier after eradication be-
cause of the vanishing of the inflammation. However,
the change of intraobserver agreement for atrophy before
and after eradication differed by endoscopist and endosco-
pist: 7 increased and 5 decreased after eradication. Our
hypothesis may be denied.
There are several limitations in the present study.
First, the number of assessors is limited. These assessors
may not be representative of experienced and beginner
endoscopists. However, each group consisted of 3 asses-
sors, and not 2 assessors. Our results may be more accur-
ate compared with a group comprising only 2 assessors.
Similar studies should be done to verify our research
Table 4 Kappa value for the intraobserver agreement for gastric mucosa atrophy in each assessor






Japanese experienced No. 1 Kappa value 0.801 0.791 0.658 0.826
(95 % CI) (0.656-0.947) (0.6277-0.9547) (0.410-0.905) (0.496-1.157)
Japanese experienced No. 2 Kappa value 0.585 0.601 0.351 0.521
(95 % CI) (0.439-0.730) (0.4369-0.7649) (0.122-0.580) (0.201-0.841)
Japanese experienced No. 3 Kappa value 0.871 0.862 0.874 0.906
(95 % CI) (0.718-1.025) (0.6918-1.0321) (0.591-1.157) (0.533-1.279)
Vietnamese experienced No. 1 Kappa value 0.680 0.625 0.452 0.613
(95 % CI) (0.530-0.831) (0.225-1.025) (0.180-0.723) (0.222-1.008)
Vietnamese experienced No. 2 Kappa value 0.740 0.630 0.677 0.820
(95 % CI) (0.589-0.891) (0.230-0.130) (0.465-0.888) (0.484-1.156)
Vietnamese experienced No. 3 Kappa value 0.728 0.495 0.716 0.666
(95 % CI) (0.581-0.875) (0.095-0.895) (0.481-0.950) (0.353-0.997)
Japanese beginner No. 1 Kappa value 0.664 0.703 0.514 0.501
(95 % CI) (0.517-0.810) (0.5388-0.8678) (0.294-0.733) (0.170-0.832)
Japanese beginner No. 2 Kappa value 0.429 0.485 0.324 0.195
(95 % CI) (0.273-0.585) (0.3112-0.6583) (0.110-0.538) (-0.163-0.554)
Japanese beginner No. 3 Kappa value 0.264 0.261 0.261 0.275
(95 % CI) (0.118-0.410) (0.0961-0.4248) (0.039-0.484) (-0.045-0.596)
Vietnamese beginner No. 1 Kappa value 0.714 0.630 0.753 0.346
(95 % CI) (0.563-0.866) (0.230-0.130) (0.520-0.986) (0.023-0.669)
Vietnamese beginner No. 2 Kappa value 0.531 0.792 0.575 0.188
(95 % CI) (0.373-0.688) (0.392-1.192) (0.368-0.781) (-0.170-0.546)
Vietnamese beginner No. 3 Kappa value 0.866 1.000 0.725 1.000
(95 % CI) (0.720-1.012) (1.000-1.000) (0.508-0.942) (0.674-1.326)
Table 3 Kappa value for the interobserver agreement for gastric mucosa atrophy in each group
Assessor groupa All (n = 91) H. pylori-uninfected (n = 24) H. pylori-currently infected (n = 48) H. pylori-past infected (n = 19)
Japanese experienced Kappa value 0.474 0.583 0.295 0.401
(95 % CI) (0.390-0.558) (0.352-0.814) (0.151-0.438) (0.212-0.589)
Vietnamese experienced Kappa value 0.408 0.458 0.344 0.141
(95 % CI) (0.323-0.493) (0.232-0.684) (0.208-0.479) (-0.044-0.326)
Japanese beginner Kappa value 0.291 0.375 0.275 0.136
(95 % CI) (0.207-0.376) (0.201-0.549) (0.146-0.403) (-0.051-0.322)
Vietnamese beginner Kappa value 0.373 0.416 0.255 0.205
(95 % CI) (0.289-0.457) (0.190-0.642) (0.133-0.376) (0.021-0.390)
aEach assessor group consists of 3 assessors
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results. Second, the number of images assessed is rela-
tively limited. If more images were assessed, more detailed
findings could be obtained. Third, there could be false-
positives or false-negatives in the diagnosis of H. pylori
status. We adopted at least 2 methods for diagnosis; how-
ever, the possibilities for misdiagnosis cannot be denied.
Finally, information on the period after H. pylori eradica-
tion was not available in all subjects because in some, H.
pylori had been eradicated unintentionally, and some had
forgotten when the eradication treatment was performed.
As a next investigation, we are planning to assess endo-
scopic gastric mucosa atrophy using 3 image sets from
identical subjects, for example, before, 1, and 3 years after
eradication. With the investigation, we may be able to
clarify in detail the changes of interobserver and intraob-
server agreement after eradication.
Conclusions
We demonstrated that interobserver agreement for gas-
tric mucosa atrophy was moderate in experienced
endoscopists, suggesting that better guidelines and firm
criteria may be needed to properly diagnose and grade
gastric atrophy.
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